Antimicrobial Studies

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment.

Studies suggest that compounds from Artemisia annua, a plant historically used to treat malaria, rheumatoid arthritis, and other illnesses, could have anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) properties. In a search for peer-reviewed articles, 19 studies were examined and found that artemisinins demonstrated inhibitory properties against coronavirus-host proteins. The combination of A. annua's biological properties, action on different signaling pathways, and a multi-drug combined-therapy approach may help inhibit SARS-CoV-2 and assist in the treatment of coronavirus disease 2019 (COVID-19).

Fuzimoto AD et al (2021).
J Integr Med.
PubMed:
34479848